Table 1.
Outpatients visit priorities for the management of pancreatic cancer
| High priority | Medium priority | Low priority |
| Patients with newly diagnosed resectable cancer—convert as many visits as possible to telemedicine appointments and schedule a multidisciplinary assessment in order to plan surgery | Established patients with new minor to moderate problems or symptoms—convert as many visits as possible to telemedicine appointments | Postoperative patients with no complications |
| Potentially unstable patients (complications in the post-surgery recovery period: anastomotic leak, bleeding, acute pancreatitis, fistulae, pneumonitis; jaundice; acute abdominal pain consistent with upper or lower intestinal occlusion; symptomatic ascites) | Follow-up visits considering patients at high risk of relapse | Established patients with no new issues |
| Patients newly diagnosed with non-resectable (locally advanced) or metastatic cancer and symptoms such as jaundice, pain, weight loss | Survival follow-up visits out of clinical trials |